NCT05104658Active, not recruiting
Heart Rehabilitation for All
Heart Rehabilitation for All: A Feasibility Randomised Trial
Source: ClinicalTrials.gov · Last updated 26 Aug 2024
Brief summary (registry, in English)
Today, 50 % of cardiac patients do not participate in cardiac rehabilitation due difficulties in navigating and accessing rehabilitation activities. HeRTA is a partnership project involving Center for Clinical Research and Prevention (CCRP), Hvidovre Hospital, Rehabilitation Center Albertslund and Copenhagen (municipalities), the Danish Heart Association, and local sports associations. A patient advisory board participate throughout the project to ensure a continued focus on patient interests. The overall aim of HeRTA is to develop and test the feasibility of a new, sustainable model for rehabilitation supporting patients to take part in rehabilitation and promoting life-long activity for all patients with heart disease. To ensure equal access to rehabilitation some activities are open to all patients, while others are tailored specifically to patients with vulnerability. The project unfolds in three phases: Development (1. January 1. 2020 - 14. November 2021): Partners and patients co-create content and procedures; Feasibility (15. November 2021 - 31. July 2023): The feasibility of the model is tested, and promising components are identified; Long-term follow-up and implementation (1. August 2023 - 31. December 2025): Long term effects are investigated and promising components are tested in new settings. During the feasibility phase the investigators will examine whether the intervention activities are feasible, acceptable, and may have positive effects for patients with heart disease. The investigators use qualitative data on implementation and acceptability of intervention among partners and patients. An randomisered controlled trial (RCT) component will assess effects on patient participation rates, health, physical activity level, and life quality. Data is collected from practitioners and patients through focus groups, observations, field notes, questionnaires, and interviews. Results will point to: * innovative ways to organize integrated rehabilitation pathways. * approaches to ensuring rehabilitation targeted at patient needs.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 218 (estimated)
- First submitted
- 27 Sept 2021
- Start date
- 1 Apr 2022
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Center for Clinical Research and Prevention
- NCT number
- NCT05104658
What you commit to
- Study type: Interventional
- Planned participants: 218
- From 1 Apr 2022 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients, who do not meet the inclusion criteria.
Who the study is looking for
- Diagnosed with ischaemic heart disease, cardiac valve surgery, persistent atrial fibrillation, or heart failure
- Resident in Hvidovre Hospitals uptake area
- Cognitively functional
- Physically able to participate in rehabilitation activities
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Center for Clinical Research and Prevention Coordinator of this site? Confirm its status | Frederiksberg | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.